Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD

1Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

2Steno Diabetes Center Copenhagen, Herlev, Denmark

3BHF/University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK

4Department of Nephrology. University Clinical Hospital. Valencia. Valencia. INCLIVA Research Institute. University of Valencia. Valencia. Spain

5Nephrology Department, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Research, Barcelona, Spain

6Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden

7George Institute for Global Health, Australia

aCorrespondence: Hiddo J. Lambers Heerspink, PhD, Department of Clinical Pharmacy and Pharmacology, University of Groningen, Hanzeplein 1, PO Box 30 001, 9700 RB, Groningen, The Netherlands, Email: [email protected]

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Comments (0)

No login
gif